Purchase Order 75N94025P00543
- Not listed
- This federal contract award, with an ID of HHSN267200700593P, was issued by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), a civilian agency within the U.S. Department of Health and Human Services. The contract, a $149,842 firm-fixed-price purchase order, was awarded to Sartorius Corporation, a foreign-owned, for-profit manufacturer of laboratory equipment and solutions for the biopharmaceutical and life sciences industries. The contract, which did not have a...
- Sartorius Corporation has been awarded a $14,544.50 firm fixed price purchase order by the Department of Health and Human Services' National Institutes of Health National Institute of Diabetes and Digestive and Kidney Diseases to provide unspecified goods or services. Performance will take place in Bohemia, New York over a one year period from September 2023 through September 2024. As a subsidiary of Sartorius Aktiengesellschaft, Sartorius Corporation will serve as the prime contractor on this...
- This firm-fixed-price purchase order for $15,904.85 was awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency within the U.S. Department of Health and Human Services, to Sartorius Corporation, a foreign-owned manufacturer of laboratory equipment and biotech solutions. The contract provides for preventative maintenance services on Sartorius' proprietary IncuCyte S3 live-cell analysis systems over a period ending on December 20, 2025. As a key supplier...
- The Department of Health and Human Services' National Institute of Allergy and Infectious Diseases (NIAID) awarded a firm fixed-price purchase order contract to Sartorius Corporation, a foreign-owned manufacturer of laboratory equipment and solutions. The $16,530.00 annual service agreement is for an IncuCyte SX5 system, which supports biomedical research and drug development activities. Sartorius, a division of the parent company Sartorius Aktiengesellschaft, has a history of providing advanced...
- This is a $21,394.00 firm fixed-price purchase order awarded by the National Cancer Institute (NCI) to Sartorius Corporation, a foreign-owned, for-profit manufacturer of laboratory equipment and solutions. The contract is for the maintenance of an IncuCyte SX5 live cell imaging system used for real-time cell health and viability measurements to support biomedical research. The award has an ultimate completion date of April 30, 2026 and was not set aside for any specific business type....
- This is a $21,394.00 firm-fixed-price purchase order contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH), to Sartorius Corporation, a foreign-owned manufacturer of laboratory equipment and solutions. The contract is for annual maintenance and software upgrades for an IncuCyte live-cell imaging device. The contract has an ultimate completion date of April 30, 2026 and was not set aside for any specific...
- This is a $36,423 firm fixed-price purchase order awarded by the National Institute on Aging (NIA), a civilian agency of the U.S. Department of Health and Human Services, to Sartorius Corporation, a foreign-owned manufacturer of laboratory equipment and solutions for the biopharmaceutical and life sciences industries. The contract is for maintenance and repair services for IncuCyte S3/IncuCyte SX5 live cell analysis systems over the period of performance from August 15, 2024 through August 14,...
- Sartorius Corporation has been awarded a firm fixed price purchase order totaling $14,900 by the Department of Health and Human Services' National Institutes of Health National Cancer Institute. The contract is for service of the agency's IncuCyte S3 live-cell imaging system located in Bethesda, Maryland, with a period of performance through March 2025. As a manufacturer of laboratory equipment and provider of services to the biopharmaceutical and research industries, Sartorius Corporation...
- The Department of Health and Human Services National Institutes of Health National Cancer Institute awarded a $14,544.50 firm fixed price purchase order to Sartorius Corporation for preventative maintenance and service of an IncuCyte S3. Sartorius Corporation, a division of Sartorius Aktiengesellschaft, will provide the requested products and services at a location in Bethesda, Maryland through November 2024. The award utilizes a National Institutes of Health contract vehicle to procure services...
- This is a one-year service contract awarded by the National Cancer Institute (NCI), a civilian agency within the U.S. Department of Health and Human Services, to Sartorius Corporation, a foreign-owned manufacturer of laboratory equipment and solutions. The contract, valued at $15,969.52, is for the maintenance and servicing of a Sartorius Incucyte* live-cell analysis system, serial number IC51523, during the period from March 1, 2025, to February 28, 2026. The contract is a firm-fixed-price...
The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) awarded a firm fixed-price purchase order to Sartorius Corporation for annual service maintenance of an IncuCyte S3 live-cell analysis system (Serial #IC51363). This $15,969.50 contract, issued on September 1, 2025, with completion by August 31, 2026, supports the agency's biomedical research operations. Sartorius Corporation, a subsidiary of German multinational Sartorius Aktiengesellschaft headquartered in Bohemia, New York, specializes in providing advanced scientific instrumentation and technical services to the life sciences and biopharmaceutical industries. The award was made without a set-aside designation and represents the type of specialized maintenance support that Sartorius routinely provides to NIH and its subsidiary institutes. This contract reflects NIDDK's ongoing investment in advanced laboratory infrastructure for metabolic and disease research. Sartorius has established itself as a consistent federal contractor, particularly within the Department of Health and Human Services, providing critical maintenance and service agreements for high-precision scientific equipment that enables cutting-edge research. The IncuCyte platform is widely utilized in drug development, disease modeling, and translational science applications, making reliable maintenance essential to research continuity across the institute's programs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $16.0k | 8/28/25 |